Blog

Research!America is dedicated to ensuring a strong public and private sector investment in research to improve health at a level warranted by scientific opportunity and supported by public opinion. Member organizations and others share their perspectives on a wide variety of topics relating to public and private sector research and innovation, and public health. The views expressed by contributors are their own and not the view of Research!America.

Recent Blog Posts

We extend our deepest condolences to Senator Arlen Specter’s family, friends and colleagues as they mourn the passing of a loved and respected statesman and a true champion of medical research. Specter’s leadership in generating critical support for medical and health research is a testament to his dedication to improving the health of all Americans and securing our position as a global leader in science and innovation. As a congressional leader, Specter played a pivotal role in the doubling of the National Institutes of Health (NIH) budget over five years and two Administrations and in 2009 assured that funding for the NIH and other health agencies were included in the American Recovery...
Why do you think we should be investing in global health research and development? Research!America has just released ’€œTop 10 Reasons Why the U.S. Should Invest in Global Health R&D.’€ This evidence-based list provides compelling reasons why these investments are critical for the U.S., ranging from the humanitarian benefits to research as a powerful driver of U.S. economic activity. The list can be found on Research!America’€™s new Global Health R&D Advocacy website . The site introduces Research!America’€™s new initiative for neglected tropical diseases (NTDs), including a recently released fact sheet on NTDs in the U.S. Additional NTD resources include a global health budget...
Dear Research Advocate, This week’€™s Nobel Prize announcements are a fine reminder of how government-supported research plays a critical role in expanding our knowledge, leading not only to worldwide recognition but taking us closer to understanding and curing disease. The winners of the prize for chemistry, Dr. Robert Lefkowitz, Howard Hughes Medical Research investigator and professor at Duke University Medical Center, and Dr. Brian Kobilka of Stanford University School of Medicine both received grants from the National Institutes of Health, as did one of the physiology and medicine awardees, Dr. Shinya Yamanaka. They are among the many Nobel laureates whose important work throughout the...
October 10, 2012 We congratulate Dr. Robert Lefkowitz and Dr. Brian Kobilka on the announcement of the Nobel Prize in chemistry for their groundbreaking work on protein receptors, paving the way for the development of new drugs to halt the rampage of disease. Patients benefit from unwavering commitment to putting research to work. Lefkowitz, an investigator at the Howard Hughes Medical Institute and professor at Duke University Medical Center, and Kobilka of Stanford University School of Medicine, have demonstrated that scientific discovery is the result of painstaking work supported by both the public and private sector. Throughout their careers, both have received government funding for...
On October 11 th , World Sight Day , the World Health Organization will raise awareness about visual impairment around the world, as well as their Vision 2020 initiative aimed at eliminating avoidable blindness by 2020. WHO estimates that 285 million people worldwide are visually impaired and about 39 million of those individuals are permanently blind. However, up to 80% of these cases are due to preventable causes like cataracts, glaucoma, diabetes, trachoma and onchocerciasis. The last two causes on that list may not sound familiar ’€“ trachoma and onchocerciasis are two types of neglected tropical diseases (NTDs), diseases that have historically received little attention despite...
On September 30, The Washington Post highlighted efforts in Haiti to eliminate lymphatic filariasis, commonly known as elephantiasis. A neglected tropical disease (NTD), elephantiasis is a parasitic infection spread by mosquitoes that can lead to swelling of the arms or legs ’€” sometimes severely enough that individuals with the disease are stigmatized or unable to work. The good news is that elephantiasis can be prevented with anti-parasitic medicines. The Centers for Disease Control and Prevention and the U.S. Agency for International Development’€™s NTD program have taken a leadership role in administering these drugs in countries that are affected by elephantiasis. U.S. public health...
We don’t usually link to blogs that focus on Baylor University’s athletic teams, but today is as good as any. The manager of the Our Daily Bears blog, Mark C. Moore, wrote a heartrending post on his young son’s diagnosis and prognosis with spinal muscular atrophy . Shortly after William was born, a friend remarked that he looked like a ragdoll in his mother’s arms; the comment stuck with Mark and Beth, his wife. They called a doctor, who was able to see them on October 4, 2011; that was the beginning of a journey that led to teams of doctors at both Children’s Medical Center (in Dallas) and UT Southwestern. The 1-year anniversary was the occasion for the blog post. The SMA Foundation notes...
Brian Vastag, science reporter at The Washington Post, recently found himself infected with the very disease he had been reporting on for months: West Nile virus. Detailing the raging fevers, interrupted sleep patterns and tingling in his arms and feet, he called himself a ’€œWest Nile zombie.’€ Brian’€™s story highlights the importance of research to develop new prevention, diagnostic and treatment methods for West Nile virus. It took eight weeks and several doctors before an infectious-disease specialist was able to correctly diagnose him with West Nile. Once diagnosed, he still had to endure the fevers, joint aches, headaches and interrupted work and simply wait for the virus to go away...
October 3, 2012 The first Presidential debate was a missed opportunity for the candidates to outline a vision for putting research and innovation to work to improve health and strengthen the economy. Fleeting references to science and research failed to give voters confidence in this regard. We learned some things in this debate, but we are still — many of us literally — dying to know what either candidate will do to assure that research for health will be a priority for this nation. Without medical progress, driven by research and innovation, there will be no chance of controlling health care costs or assuring our nation’s continued leadership in the life sciences. We strongly urge the...
Dear Research Advocate, The first presidential debate gave us little to go on regarding research for health. Americans are dying to know more ’€“ many, quite literally dying ’€“ about what either presidential candidate would do to speed up medical progress in the face of Alzheimer’€™s disease, Parkinson’€™s disease, ALS and the host of other disabling and deadly health threats that breed suffering, compromise independence and drive spiraling health care costs. Add to that the pivotal role medical innovation plays in our economy, and Americans absolutely deserve to know whether candidates will champion or shortchange it. All of us must say to candidates: Tell us what you will do, share your...

Pages

We have health challenges in this country that science will provide answers for if given the chance and we haven't given science that opportunity
Mary Woolley, President and CEO, Research!America